Vitamin D Supplementation for the Prevention of Acute Respiratory Infections: a RCT in Young Finnish Men
NCT ID: NCT05014048
Last Updated: 2023-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
231 participants
INTERVENTIONAL
2018-01-04
2018-05-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infections
NCT00973583
Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
NCT04810949
Study of Vitamin D for the Prevention of Acute Respiratory Infections in Children
NCT02046577
A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections
NCT01158560
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
NCT04596657
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vitamin D3
20 mikrog vitamin D3 daily, 3 months
Vitamin D3
20 mikrog vitamin D3 daily
Placebo
Placebo
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D3
20 mikrog vitamin D3 daily
Placebo
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-29 years of age
* examined as Healthy according to Finnish Military Health Care regulations
Exclusion Criteria
* age \> 30 yrs
18 Years
29 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Finnish Defense Forces
OTHER_GOV
Tampere University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ilkka Laaksi
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ilkka laaksi, MDPhD
Role: PRINCIPAL_INVESTIGATOR
University of Tampere, Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Finnish Defence Forces
Hämeenlinna, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Laaksi A, Kyrolainen H, Pihlajamaki H, Vaara JP, Luukkaala T, Laaksi I. Effects of Vitamin D Supplementation and Baseline Vitamin D Status on Acute Respiratory Infections and Cathelicidin: A Randomized Controlled Trial. Open Forum Infect Dis. 2024 Aug 27;11(9):ofae482. doi: 10.1093/ofid/ofae482. eCollection 2024 Sep.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UTampere
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.